User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
(→Lymphoma: + 'Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation ' at ncbi.nlm.nih.gov , a '''2008''' study, published in w:International Journal of Cancer) |
(→Lymphoma: + 'Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism ' at ncbi.nlm.nih.gov, a '''2009''' study, published in w:Molecular Cancer Research) |
||
| Line 389: | Line 389: | ||
== Lymphoma == | == Lymphoma == | ||
[[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia) | [[w:Hodgkin's lymphoma|Hodgkin's lymphoma]] is a type of [[w:lymphoma|lymphoma]] in which [[w:cancer|cancer]] originates from a specific type of [[w:white blood cell|white blood cell]]s called [[w:lymphocyte|lymphocyte]]s. (Wikipedia) | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/19609004 'Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2009''' study, published in [[w:Molecular Cancer Research]] | |||
* [http://www.ncbi.nlm.nih.gov/pubmed/18546271 'Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2008''' study, published in [[w:International Journal of Cancer]] | * [http://www.ncbi.nlm.nih.gov/pubmed/18546271 'Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation ' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a '''2008''' study, published in [[w:International Journal of Cancer]] | ||